Vision therapy helps brain injury patients

Article

Stroke and traumatic brain injury survivors, who have undergone vision restoration therapy (VRT), demonstrate increased brain activity, according to researchers from Columbia University Medical Center, USA.

Stroke and traumatic brain injury survivors, who have undergone vision restoration therapy (VRT), demonstrate increased brain activity, according to researchers from Columbia University Medical Center, USA.

Randolph Marshall and colleagues examined the functional magnetic resonance imaging (fMRIs) of six patients aged between 35 and 77 with homonymous hemianopia vision loss caused by stroke or traumatic brain injury. Each patient underwent VRT therapy to help rehabilitate their vision.

The fMRI data showed that there was an increased activity in the visual processing areas of the brain as patients learned to detect stimuli in the border zone between the seeing and non-seeing fields. This enhanced activity was identified one month after the start of treatment, suggesting that the brain responds accordingly.

The treatment involves patients performing daily therapy at home for between six and seven months, gradually improving their vision through repeated detection of light stimuli directed at the border between the seeing and blind areas of the visual field.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
3 experts are featured in this series.
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
3 experts are featured in this series.
© 2025 MJH Life Sciences

All rights reserved.